Pfizer to deliver 10% more doses to U.S. by end of May- CEO
- Wall Street ends volatile week sharply higher
- AT&T (T) in Talks to Merge Media Assets with Discovery (DISCA) - WSJ
- Disney (DIS) Dips As Streaming Business Shows Signs of Slowing Down, Analysts 'Very Bullish' on LT Opportunity
- Airbnb (ABNB) Bookings Up 52% to Help Sales Beat, Seen as a 'Blow Out Quarter' as More Upside is Left
- DoorDash (DASH) Reports Bigger Loss and a Sales Beat, Shares Soars on Strong Guidance and Two Upgrades to 'Buy'
FILE PHOTO: A healthcare worker prepares a Pfizer coronavirus disease (COVID-19) vaccination in Los Angeles, California, U.S., January 7, 2021. REUTERS/Lucy Nicholson/File Photo
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
(Reuters) -Pfizer Inc can deliver 10% more doses of its COVID-19 vaccine to the United States by the end of May and meet its target of supplying 300 million doses two weeks earlier than expected, Chief Executive Officer Albert Bourla said in a tweet on Tuesday.
Pfizer had promised to provide the U.S. government with 100 million doses by the end of March and another 100 million by the end of May, with the rest being delivered by the end of July.
Separately, the company said it had conducted an assessment of the vaccines' safety data and had found no evidence of blood clots.
"This safety database analysis includes a review of all adverse events received for the vaccine through March 27," the company said.
Pfizer's statement comes as U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson's COVID-19 vaccine for at least a few days after six women under age 50 developed rare blood clots after receiving the shot.
(Reporting by Dania Nadeem in Bengaluru; Editing by Anil D'Silva)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sudan seeks debt relief pledges, investment at Paris conference
- Dollar edges higher as virus restrictions unnerve investors
- G7 urged to donate 'emergency' supplies to vaccine-sharing scheme
Create E-mail Alert Related CategoriesGeneral News, Reuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!